Target intelligence / Profile preview

Ribosomal protein L12 pseudogene 18 (RPL12P18)

Target: RPL12P18
Molecular classification: Other (pseudogene)

Overview

Ribosomal protein L12 pseudogene 18 (RPL12P18) is a non-coding, processed pseudogene in humans that shares sequence similarity with the ribosomal protein L12 gene. It does not produce a functional protein and is one of many pseudogenes dispersed throughout the human genome that derive from ribosomal protein genes. Pseudogenes like RPL12P18 arise from duplication or retrotransposition events and generally do not participate in cellular processes, encode proteins, or act as therapeutic targets[2][1].

Other names: RPL12_3_246RPL12P18

Beyond the preview

Go deeper on Ribosomal protein L12 pseudogene 18 (RPL12P18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L12 pseudogene 18 (RPL12P18).

Explore the full profile